How many institutions held PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in Q2 2021?

99 institutional investors reported PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share for Q2 2021. Use the holders table for investor-level position and value details.

Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Q: What does CUSIP 702712100 represent in this 13F holders report?

CUSIP 702712100 is the security identifier for PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 702712100

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 3,182,163
Total 13F shares: 42,094,204
Share change: -401,154
Total reported value: $557,333,406
Price per share: $13.24
Number of holders: 99
Value change: -$6,360,822
Number of buys: 62
Number of sells: 26

Quarterly Holders Quick Answers

What is CUSIP 702712100?
CUSIP 702712100 identifies PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 702712100:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	254%	8,074,687	$141,147,000	—	31 Mar 2021	13F
ORBIMED ADVISORS LLC	13F	Company	219%	6,962,899	$121,711,000	—	31 Mar 2021	13F
FRAZIER MANAGEMENT LLC	13F	Company	157%	5,009,219	$87,561,000	—	31 Mar 2021	13F
Versant Venture Management, LLC	13F	Company	156%	4,959,769	$86,697,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	94%	3,001,646	$52,468,000	—	31 Mar 2021	13F
New Leaf Venture Partners, L.L.C.	13F	Company	78%	2,497,922	$43,664,000	—	31 Mar 2021	13F
Boxer Capital, LLC	13F	Company	61%	1,928,315	$33,707,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	56%	1,785,237	$31,206,000	—	31 Mar 2021	13F
Vivo Capital, LLC	13F	Company	44%	1,413,508	$24,708,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	43%	1,358,902	$23,753,000	—	31 Mar 2021	13F
HIGHLINE CAPITAL MANAGEMENT, L.P.	13F	Company	27%	870,948	$15,224,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	21%	675,687	$11,811,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	19%	605,796	$10,589,000	—	31 Mar 2021	13F
EMERALD ADVISERS, LLC	13F	Company	16%	499,541	$8,732,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	14%	444,490	$7,769,000	—	31 Mar 2021	13F
Alyeska Investment Group, L.P.	13F	Company	11%	338,807	$5,922,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	11%	335,125	$5,858,000	—	31 Mar 2021	13F
MARSHALL WACE, LLP	13F	Company	9.9%	315,870	$5,521,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	9.5%	303,532	$5,306,000	—	31 Mar 2021	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	9.4%	297,713	$5,204,000	—	31 Mar 2021	13F
Marshall Wace North America L.P.	13F	Company	8.9%	283,175	$4,950,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	8.8%	281,032	$4,913,000	—	31 Mar 2021	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	8.3%	264,911	$4,631,000	—	31 Mar 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	7.4%	235,362	$4,114,000	—	31 Mar 2021	13F
Point72 Asset Management, L.P.	13F	Company	7%	222,200	$3,884,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	5.6%	176,688	$3,089,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	4.6%	145,858	$2,550,000	—	31 Mar 2021	13F
Logos Global Management LP	13F	Company	3.9%	125,010	$2,185,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	3.8%	120,860	$2,112,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	3.6%	113,439	$1,983,000	—	31 Mar 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.4%	109,700	$1,918,000	—	31 Mar 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	3.2%	100,965	$1,764,000	—	31 Mar 2021	13F
Rafferty Asset Management, LLC	13F	Company	2.9%	90,792	$1,587,000	—	31 Mar 2021	13F
ROYCE & ASSOCIATES LP	13F	Company	2.6%	84,000	$1,468,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.4%	76,418	$1,336,000	—	31 Mar 2021	13F
Granite Point Capital Management, L.P.	13F	Company	2.4%	75,000	$1,311,000	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	1.7%	53,700	$939,000	—	31 Mar 2021	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	1.7%	52,886	$924,000	—	31 Mar 2021	13F
Squarepoint Ops LLC	13F	Company	1.7%	52,802	$923,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	1.6%	50,736	$887,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	1.4%	43,374	$758,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	1.3%	41,464	$725,000	—	31 Mar 2021	13F
Vontobel Holding Ltd.	13F	Company	0.94%	30,000	$524,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.92%	29,280	$512,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.92%	29,221	$511,000	—	31 Mar 2021	13F
Migdal Insurance & Financial Holdings Ltd.	13F	Company	0.89%	28,267	$494,000	—	31 Mar 2021	13F
Ensign Peak Advisors, Inc	13F	Company	0.81%	25,650	$448,000	—	31 Mar 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.8%	25,339	$443,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.76%	24,176	$423,000	—	31 Mar 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.71%	22,500	$393,000	—	31 Mar 2021	13F

Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q2 2021

As of 30 Jun 2021, Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,094,204 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FMR LLC, FRAZIER MANAGEMENT LLC, Versant Venture Management, LLC, BlackRock Inc., BOXER CAPITAL, LLC, VANGUARD GROUP INC, STATE STREET CORP, MORGAN STANLEY, and HIGHLINE CAPITAL MANAGEMENT, L.P.. This page lists 99 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.